브레인 컴퓨터 인터페이스 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 부문별 예측(2026-2033년)

Brain Computer Interface Market Summary

The global brain computer interface (BCI) market, considering invasive BCIs, the total addressable market (TAM) was estimated at USD 168.27 billion in 2025 and is expected to grow at a CAGR of 1.52% from 2026 to 2033. Several research studies indicate that invasive BCIs offer a higher level of assurance in restoring motor function and communication capabilities in patients with conditions such as Amyotrophic Lateral Sclerosis (ALS), spinal cord injuries, and stroke.

In contrast, considering non-invasive BCIs, the serviceable obtainable market (SOM) was estimated at USD 397.59 million in 2025 and is projected to grow at a CAGR of 8.73% from 2026 to 2033. Key market drivers include the increasing prevalence of conditions requiring neuroprosthetic devices, the rising global geriatric population, and technological advancements that facilitate communication and movement in paralytic patients. Additionally, the expanding use of non-invasive BCIs in home control systems, virtual gaming, and military communication further enhances market applicability, thereby supporting market growth.

BCI technology is primarily utilized in medical and research settings to assist individuals with disabilities in controlling prosthetic limbs or restoring their communication ability. These systems employ electrodes placed on the scalp or implanted in the brain to capture and interpret neural signals, which are then converted into commands for external devices. Recently, advancements in BCI technology have made it more accessible, affordable, and versatile. Consumer-grade BCI devices, such as the Muse and NeuroSky headsets, are available in the market. These headsets utilize wireless dry electrodes that eliminate the need for conductive gel, making them comfortable for users to wear for extended periods. Thus, the availability of such products in the market boosts the market growth.

The increasing prevalence of neurodegenerative disorders is a significant driver of growth in the BCI market. Neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS), are characterized by the progressive degeneration of neurons, leading to a gradual loss of function in the affected areas of the brain and nervous system.

According to the WHO report, around 82 million people will be affected by dementia by 2030 and this number will reach 152 million by 2050. This shows the potential demand for BCI in the coming years. These conditions can severely impact an individual's motor functions, communication abilities, and overall quality of life. As the global population ages, the incidence of these disorders is expected to rise, creating a pressing need for innovative solutions that can help manage symptoms, restore lost functions, and improve the lives of affected individuals.

Global Brain Computer Interface Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global brain computer interface market report based on product, application, end use, and region:

• Brain-Computer Interface (BCI) Product Outlook (Revenue, USD Million, 2021 - 2033)
• Invasive Brain-Computer Interface (BCI) [Total Addressable Market (TAM)]
• Non Invasive Brain-Computer Interface (BCI) [Serviceable Obtainable Market (SOM)]
• Invasive Brain-Computer Interface (BCI) Application Outlook :(Revenue in USD Million; 2021 - 2033) [Total Addressable Market (TAM)]
• MND/ALS
• Stroke
• Spinal Cord Injury
• Multiple Sclerosis Patients
• Cerebral Palsy
• Amputation
• Epilepsy
• Depression
• Parkinson's Disease
• Non Invasive BCI Application Outlook (Revenue in USD Million; 2021 - 2033) [Serviceable Obtainable Market (SOM)]
• Healthcare
  • Disabilities Restoration
  • Brain Function Repair
• Smart Home Control
• Communication and control
• Entertainment & Gaming
• Non Invasive BCI End Use Outlook (Revenue in USD Million, 2021 - 2033) [Serviceable Obtainable Market (SOM)]
• Medical
• Education & Research
• Others (Consumer & Wellness, etc.)
• Non Invasive BCI Regional Outlook (Revenue, USD Million, 2021 - 2033) [Serviceable Obtainable Market (SOM)]
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Application
  • 1.1.2. End Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Brain Computer Interface Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market driver analysis
  • 3.1.2. Market restraint analysis
  • 3.1.3. Market Opportunities
• 3.2. Brain Computer Interface Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Supplier power
    • 3.2.1.2. Buyer power
    • 3.2.1.3. Substitution threat
    • 3.2.1.4. Threat of new entrant
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape
  • 3.2.3. Clinical Trial Pipelines in the BCI Technologies
  • 3.2.4. Case Studies

Chapter 4. Invasive Brain-Computer Interface (BCI) Total Addressable Market (TAM) Application Estimates & Trend Analysis

• 4.1. Application Market Share, 2025 & 2033
• 4.2. Segment Dashboard
• 4.3. Global Brain Computer Interface Market by Application Outlook
• 4.4. MND/ALS
  • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.5. Stroke
  • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.6. Spinal Cord Injury
  • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.7. Multiple Sclerosis Patients
  • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.8. Cerebral Palsy
  • 4.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.9. Amputation
  • 4.9.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.10. Epilepsy
  • 4.10.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.11. Depression
  • 4.11.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.12. Parkinson's Disease
  • 4.12.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Non-Invasive Brain Computer Interface Market: Application Estimates & Trend Analysis

• 5.1. Indication Market Share, 2025 & 2033
• 5.2. Segment Dashboard
• 5.3. Global Brain Computer Interface Market by Indication Outlook
• 5.4. Healthcare
  • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.4.2. Disabilities Restoration
  • 5.4.3. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.4.4. Brain Function Repair
  • 5.4.5. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Smart Home Control
  • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.6. Communication and control
  • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.7. Entertainment & Gaming
  • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Non-Invasive Brain Computer Interface Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2025 & 2033
• 6.2. Segment Dashboard
• 6.3. Global Brain Computer Interface Market by End Use Outlook
• 6.4. Medical
  • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Education & Research
  • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Non-Invasive Brain Computer Interface Market: Regional Estimates & Trend Analysis, By Type

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share/position analysis, 2025
• 8.4. Company Profiles
  • 8.4.1. Medtronic
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Technology Type benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. G.Tec medical engineering GmbH
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Technology Type benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Natus Medical Incorporated
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Technology Type benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Compumedics Neuroscan
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Technology Type benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Brain Products GmbH
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Technology Type benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Integra LifeSciences Corporation
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Technology Type benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Advanced Brain Monitoring, Inc.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Technology Type benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. EMOTIV
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Technology Type benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. NeuroSky
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Technology Type benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. ANT Neuro
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Technology Type benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. NIRx Medical Technologies, LLC
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Technology Type benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Ripple Neuro.
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Technology Type benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Neuroelectrics
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Technology Type benchmarking
    • 8.4.13.4. Strategic initiatives
  • 8.4.14. OpenBCI
    • 8.4.14.1. Company overview
    • 8.4.14.2. Financial performance
    • 8.4.14.3. Technology Type benchmarking
    • 8.4.14.4. Strategic initiatives
  • 8.4.15. COGNIONICS, INC. (CGX)
    • 8.4.15.1. Company overview
    • 8.4.15.2. Financial performance
    • 8.4.15.3. Technology Type benchmarking
    • 8.4.15.4. Strategic initiatives
  • 8.4.16. Blackrock Neurotech
    • 8.4.16.1. Company overview
    • 8.4.16.2. Financial performance
    • 8.4.16.3. Technology Type benchmarking
    • 8.4.16.4. Strategic initiatives
  • 8.4.17. Synchron
    • 8.4.17.1. Company overview
    • 8.4.17.2. Financial performance
    • 8.4.17.3. Technology Type benchmarking
    • 8.4.17.4. Strategic initiatives
  • 8.4.18. Neurable
    • 8.4.18.1. Company overview
    • 8.4.18.2. Financial performance
    • 8.4.18.3. Technology Type benchmarking
    • 8.4.18.4. Strategic initiatives